Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia
Abstract ETV6::RUNX1 is the most common fusion gene in childhood acute lymphoblastic leukemia (ALL) associated with favorable prognosis, but the optimal therapy for this subtype remains unclear. Profiling the genomic and pharmacological landscape of 194 pediatric ETV6::RUNX1 ALL cases, we uncover tw...
Saved in:
Main Authors: | Zhenhua Li, Huanbin Zhao, Wenjian Yang, Maud Maillard, Satoshi Yoshimura, Yu-Chih Hsiao, Xin Huang, Yoshihiro Gocho, Lauren Rowland, Anthony Brown, Landon Choi, Kristine R. Crews, Charles G. Mullighan, Samuel W. Brady, Cheng Cheng, Ti-Cheng Chang, Gang Wu, Mignon L. Loh, Allen Eng Juh Yeoh, Federico Antillon-Klussmann, Sima Jeha, Hiroto Inaba, Jiyang Yu, Ching-Hon Pui, Seth E. Karol, William E. Evans, Jun J. Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-025-56229-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory Role of the RUNX2 Transcription Factor in Lung Cancer Apoptosis
by: Camila Bernal, et al.
Published: (2022-01-01) -
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism
by: Zhigang Huang, et al.
Published: (2025-02-01) -
Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency
by: Fabiola Del Carpio-Cano, et al.
Published: (2025-01-01) -
Effect of nanoemulsion carbonated hydroxyapatite-statin administration on Acp 5 and Runx-2 expression during orthodontic relapse in rats
by: Ananto Ali Alhasyimi, et al.
Published: (2025-01-01) -
Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2
by: Qi Dong, et al.
Published: (2025-01-01)